- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Fresenius, WuXi Biologics Sign Biosimilars Deal | ||
| 30.10. | Edison Scientific Inks AI Deal with Pfizer | ||
| 30.10. | Cambrex Breaks Ground on $120M Expansion at Charles City Site | ||
| 30.10. | Pace Life Sciences Completes EMA GMP Inspection at Lebanon, NJ Facility | ||
| 29.10. | BioMarin, GC Biopharma, Hanmi Pharm to Collaborate on Fabry Disease Treatment | ||
| 29.10. | Codis Completes Redundant UK Facility Demolition, Starts Construction on PSD-4 Expansion | ||
| 29.10. | Sanofi Launches Phase III Flu-COVID Vaccine Trial in Europe, Earning Novavax $125M | ||
| 29.10. | Processa Pharmaceuticals Acquires Vidya Therapeutics | ||
| 29.10. | Adial Pharmaceuticals Rebrands as Azora Therapeutics, Focuses on Ulcerative Colitis Candidate | ||
| 29.10. | Lonza Expands Bioconjugation Manufacturing in Visp | ||
| 28.10. | Twist Bioscience Launches Express Screening Antibodies, Expanding Production and Characterization Portfolio | ||
| 28.10. | Novocure and Verastem to Test Combined Therapies for Locally Advanced Pancreatic Cancer | ||
| 28.10. | Piramal Pharma Solutions' Pithampur Site Links Every Batch to Patient | ||
| 28.10. | Enthorin Enters Option-to-License Pact with Rumi for Fragile X Syndrome Therapy | ||
| 28.10. | Astellas, Audax Ink Global License Agreement for Immuno-Oncology Candidate | ||
| 28.10. | Transpharmation Acquires OrganoTherapeutics, Advancing Novel CNS Therapies | ||
| 28.10. | Alcami Promotes Robert Tragas to Vice President of Lab Services | ||
| 27.10. | Adalvo Acquires Romiplostim Biosimilar Program from Enzene | ||
| 27.10. | Aptar Pharma, Stevanato Group Partner on Pre-Filled Syringe Configuration Assessments | ||
| 27.10. | Teva Completes Acquisition of BioXcel Assets, Expands Neuroscience Pipeline | ||
| 27.10. | AstraZeneca and Daiichi Sankyo's Enhertu Gets EU Nod for Residual Treatment in HER2+ Early Breast Cancer | ||
| 27.10. | Humanitas Global Health Launches at AAPS PharmSci 360 | ||
| 27.10. | DFE Pharma Appoints Peter Rose as New Chief Operating Officer | ||
| 26.10. | Regeneron Extends BARDA Deal for Ebola Treatment Supply for $270M Through 2031 | ||
| 26.10. | FDA Expands Approval of Pfizer's Talzenna Plus Xtandi for Earlier Prostate Cancer Treatment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.